ZytoLight ® SPEC ERG/TMPRSS2 TriCheckTM Probe
The ZytoLight SPEC ERG/TMPRSS2 TriCheckTM Probe is designed to detect deletions between the ERG and the TMPRSS2 gene at 21q22 resulting in the TMPRSS2-ERG fusion frequently observed in prostate cancer. Furthermore, the triple color approach allows the detection of other translocations affecting either of these genes.
|Prod. No.:||Tests¹ (Volume):||Intended Use²:|
|1||Using 10 μl probe solution per test.|
|2||CE IVD only available in certain countries. All other countries research use only!
Please contact your local dealer for more information.